TFI International 株価情報 (NYSE: TFII)

最新ニュース TFI International (NYSE:TFII) 株価情報

TFI International

TFI International Inc is involved in the provision of transportation and logistics services across the United States, Canada, and Mexico. The company's reportable segments are; Less-Than-Truckload, which derives maximum revenue, Truckload, and Logistics. The Less-Than-Truckload segment engages in pickup, consolidation, transport, and delivery of smaller loads; the Truckload segment deals with full loads carried directly from the customer to the destination using a closed van or specialized equipment to meet customers' specific needs; and the Logistics segment provides asset-light logistics services, including brokerage, freight forwarding, and transportation management, as well as small package parcel delivery. Geographically, the company generates maximum revenue from the United States.

TFI International Inc

Trading Ideas

LXEH

Lixiang Education Shares Halted On Circuit Breaker To The Downside, Stock Now Down -66.5%

W. R. Berkley Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) will release earnings results for the first quarter, after the <a href="https://www.benzinga.com/quote/wrb/earnings">closing bell on Monday, April 21.</a>
Analysts expect the Greenwich, Connecticut-based company to report quarterly earnings at 99 cents per share, down from $1.04 per share in the year-ago period. W. R. Berkley projects to report quarterly revenue at $3.02 billion, compared to $2.76 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On March 28, W. R. Berkley confirmed that Japan&#8217;s Mitsui Sumitomo Insurance (MSI) will acquire a 15% stake through a newly announced investment and voting agreement.
W. R. Berkley shares rose 0.5% to close at $68.80 on Thursday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/wrb/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Jefferies analyst Yaron Kinar maintained a Hold rating and raised the price target from $57 to $66 on April 11, 2025. This analyst has an accuracy rate of 75%.</li>
<li>Keefe, Bruyette &amp; Woods analyst Meyer Shields maintained a Market Perform rating and slashed the price target from $64 to $62 on April 9, 2025. This analyst has an accuracy rate of 80%.</li>
<li>Wells Fargo analyst Elyse Greenspan downgraded the stock from Overweight to Equal-Weight and cut the price target from $70 to $69 on April 9, 2025. This analyst has an accuracy rate of 75%.</li>
<li>Truist Securities analyst Mark Hughes maintained a Buy rating and increased the price target from $68 to $80 on April 3, 2025. This analyst has an accuracy rate of 84%.</li>
<li>B of A Securities analyst Joshua Shanker downgraded the stock from Buy to Neutral and increased the price target from $73 to $74 on April 1, 2025. This analyst has an accuracy rate of 75%.</li>
</ul>
Considering buying WRB stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="609" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21015632/image-28-1024x609.png" alt="" class="wp-image-878922" style="width:520px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21015632/image-28-1024x609.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21015632/image-28-300x178.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21015632/image-28-768x456.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21015632/image-28.png 1077w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next:<a href="https://www.benzinga.com/25/04/44862261/top-3-materials-stocks-that-are-ticking-portfolio-bombs"> </a>
<ul>
<li><a href="https://www.benzinga.com/25/04/44862261/top-3-materials-stocks-that-are-ticking-portfolio-bombs">Top 3 Materials Stocks That Are Ticking Portfolio Bombs</a> </li>
</ul>
Photo via Shutterstock

Earnings

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Top Wall Street Forecasters Revamp W. R. Berkley Expectations Ahead Of Q1 Earnings

WIMI

WiMi Hologram Shares Halted On Circuit Breaker To The Upside, Stock Now Up 23.1%

Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares are trading lower Monday following reports that the company has postponed plans for an affordable version of its <a href="https://www.benzinga.com/25/04/44888254/elon-musks-tesla-delays-launch-of-affordable-model-y-by-several-months-report">Model Y SUV</a>.
What To Know: According to a Reuters report citing three sources with knowledge of the matter, Tesla has delayed the launch of a U.S.-made, stripped-down version of its Model Y that was originally planned for the first half of the year. 
The report indicates that production of the lower-cost version of the Model Y, codenamed E41 internally, is expected to begin at least a few months later than Tesla previously forecasted. New timelines suggest the affordable model could enter production sometime between the third quarter and early next year. 
People familiar with the matter reportedly said Tesla was aiming to produce 250,000 stripped-down Model Ys in the U.S. in 2026. The company also plans to produce the vehicle in China and Europe eventually. The vehicle is expected to cost about 20% less to make than the latest refreshed version.
The sources didn&#8217;t provide a reason for the delay, but the news comes amid rising global trade tensions following the Trump administration&#8217;s sweeping reciprocal tariffs on a slew of nations. 
The report also indicates that Tesla is planning to launch a basic version of its Model 3 sedan. CEO Elon Musk previously said the company would offer vehicles priced as low as $25,000, but he suggested the company had shifted its focus to robotaxi development instead during the company&#8217;s third-quarter earnings call. 
"I think having a regular $25,000 model is pointless. Yeah, it would be silly,&#8221; Musk <a href="https://www.benzinga.com/markets/equities/24/10/41507504/elon-musk-shuts-down-traditional-tesla-25k-ev-rumors-calls-it-pointless-as-company-focuses-on-al">said on the call</a>. 
Check This Out: <a href="https://www.benzinga.com/25/04/44896337/teslas-q1-test-drive-will-earnings-steer-tesla-stock-out-of-the-ditch">Tesla Q1 Test Drive: Will Earnings Steer The Stock Out Of The Ditch?</a>
Tesla is due to report <a href="https://www.benzinga.com/calendars/earnings">first-quarter financial results</a> after the market close on Tuesday. Analysts expect the EV maker to report earnings of 41 cents per share and revenue of $21.35 billion, according to estimates from<a href="http://pro.benzinga.com"> Benzinga Pro</a>. 
Tesla reported its first decline in annual deliveries at the beginning of the year. Analysts expect annual sales to decline again in 2025 for multiple reasons, including potential brand damage related to Musk&#8217;s close ties to the Trump administration.
Automakers are facing higher prices and potential supply-chain disruptions due to tariffs. Reuters reported that Tesla has ramped up North American parts sourcing in recent years, which could lower tariff exposure for the lower-cost Model Y, known internally as E41. 
TSLA Price Action: <a href="http://benzinga.com/quote/TSLA">Tesla shares</a> were down 5.29% at $228.45 at the time of publication Monday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/25/04/44894382/tesla-battery-supplier-catl-unveils-new-fast-charging-battery-with-323-mile-range-in-five-minutes">Tesla Battery Supplier CATL Unveils New Fast-Charging Battery With 323-Mile Range In Five Minutes</a></li>
</ul>
Photo: courtesy of Tesla.

News

Movers

TSLA

Tesla Stock Is Sliding Monday: What's Driving The Action?

Lixiang Education Shares Resume Trading

Piper Sandler analyst Biren Amin maintains Sarepta Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>) with a Overweight and lowers the price target from $182 to $110.

SRPT

Piper Sandler Maintains Overweight on Sarepta Therapeutics, Lowers Price Target to $110

TAR-200 monotherapy shows highest complete response with sustained benefits in 12-month data from Phase 2b SunRISe-1 study (Cohort 2)
Compelling first results from Cohort 4 of Phase 2b SunRISe-1 study show potential of TAR-200 monotherapy in patients with papillary-only, high-risk non-muscle invasive bladder cancer
RARITAN, N.J., April 21, 2025 /PRNewswire/ -- Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) announced today that new data from its leading oncology pipeline will be presented at the American Urological Association (AUA) 2025 Annual Meeting, taking place April 26-29 in Las Vegas. Among the highlights are the 12-month duration of response (DOR) data from the Phase 2b Cohort 2 SunRISe-1 study, evaluating TAR-200—an intravesical gemcitabine releasing system—for patients with Bacillus Calmette-Guérin (BCG)—unresponsive, high-risk non-muscle-invasive bladder cancer (HR-NMIBC) with carcinoma in situ (CIS) with or without papillary disease. These findings will be featured in the Practice-changing, Paradigm-shifting Clinical Trials in Urology&nbsp;plenary session on Saturday, April 26.
A second plenary presentation will feature first&nbsp;results from Cohort 4 of the Phase 2b SunRISe-1 study evaluating TAR-200 monotherapy in patients with BCG–unresponsive, papillary-only HR-NMIBC. In this patient population, bladder removal remains a standard treatment, but many patients are elderly, have significant comorbidities, or are unwilling to undergo radical surgery, making treatment challenging.

Johnson & Johnson Says First Results From Cohort 4 Of Phase 2B Sunrise-1 Study Show Potential Of TAR-200 Monotherapy In Patients With Papillary-only, High-risk Non-muscle Invasive Bladder Cancer

MLGO

MicroAlgo Shares Halted On Circuit Breaker To The Upside, Stock Now Up 56%

<a href="https://www.bloomberg.com/news/articles/2025-04-21/air-india-keen-to-take-boeing-planes-refused-by-chinese-airlines">https://www.bloomberg.com/news/articles/2025-04-21/air-india-keen-to-take-boeing-planes-refused-by-chinese-airlines</a>

General

'Air India Keen To Take Boeing Planes Refused By Chinese Airlines'- Bloomberg

TAR-200 monotherapy shows highest complete response with sustained benefits in 12-month data from Phase 2b SunRISe-1 study (Cohort 2)
Compelling first results from Cohort 4 of Phase 2b SunRISe-1 study show potential of TAR-200 monotherapy in patients with papillary-only, high-risk non-muscle invasive bladder cancer
RARITAN, N.J., April 21, 2025 /PRNewswire/ -- Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) announced today that new data from its leading oncology pipeline will be presented at the American Urological Association (AUA) 2025 Annual Meeting, taking place April 26-29 in Las Vegas. Among the highlights are the 12-month duration of response (DOR) data from the Phase 2b Cohort 2 SunRISe-1 study, evaluating TAR-200—an intravesical gemcitabine releasing system—for patients with Bacillus Calmette-Guérin (BCG)—unresponsive, high-risk non-muscle-invasive bladder cancer (HR-NMIBC) with carcinoma in situ (CIS) with or without papillary disease. These findings will be featured in the Practice-changing, Paradigm-shifting Clinical Trials in Urology&nbsp;plenary session on Saturday, April 26.

Johnson & Johnson Says TAR-200 Monotherapy Shows Highest Complete Response With Sustained Benefits In 12-month Data From Phase 2B SunRISe-1 Study (Cohort 2)

On Monday, Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)&nbsp;chief&nbsp;Jensen Huang&nbsp;met with Japanese Prime Minister&nbsp;Shigeru Ishiba&nbsp;to canvass more electricity to power <a target="_blank" href="https://www.benzinga.com/topic/nvidia" rel="noreferrer noopener">artificial intelligence&#8217;s needs</a>.
Huang&nbsp;and Ishiba discussed how Japan is particularly positioned well to develop AI, given its leadership in robotics and industrial manufacturing. They acknowledged the importance of electric energy generation and new infrastructure to power their AI ambitions, Bloomberg reported, <a target="_blank" href="https://www.bloomberg.com/news/articles/2025-04-21/nvidia-ceo-lobbies-japan-for-more-power-data-centers-to-fuel-ai?srnd=phx-technology&amp;sref=TBDibEcD" rel="noreferrer noopener">citing</a> Huang.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/global/25/04/44709732/foxconn-eyes-nissan-mitsubishi-in-japan-ev-push-to-counter-chinas-growing-auto-threat" rel="noreferrer noopener">Foxconn Eyes Nissan, Mitsubishi In Japan EV Push To Counter China&#8217;s Growing Auto Threat</a>
However, Huang also said that generating and creating intelligence will need energy.
Huang visited Beijing last week. Meanwhile, U.S. President Donald Trump shared plans to prohibit Nvidia from selling H20 AI chip to China amid intensifying geopolitical tensions spurred by U.S. blacklisting of Chinese companies like Huawei Technologies, semiconductor sanctions restricting China&#8217;s access to advanced semiconductor technologies, and a tariff war between the countries.
Last week, Nvidia warned of a $5.5 billion&nbsp;writedown&nbsp;from the newest U.S. chip embargo.
Redburn Atlantic analyst&nbsp;Timm Schulze-Melander&nbsp;<a target="_blank" href="https://www.benzinga.com/government/regulations/25/04/44846329/nvidias-china-sales-face-setback-as-h20-chip-restrictions-catch-key-buyers-off-guard-reuters" rel="noreferrer noopener">named Nvidia a</a> &#8216;top pick,&#8217; citing investments in leading-edge AI and chipmaking.
<a target="_blank" href="https://www.benzinga.com/25/04/44631510/asml-to-boost-japan-workforce-5x-amid-global-race-for-advanced-semiconductor-tech" rel="noreferrer noopener">Recent reports indicated</a> Dutch advanced chipmaking equipment supplier&nbsp;ASML Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>)&nbsp;plans to quintuple its Japan-based maintenance staff for the machines. Japan continues bolstering its advanced semiconductor technology position, as in the U.S., Europe, and China.
Japanese multinational investment holding company&nbsp;Softbank Group Corp (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SFTBF#OTC">SFTBF</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SFTBY#OTC">SFTBY</a>) is&nbsp;also weighing a loan&nbsp;of up to $16.5 billion to finance its&nbsp;U.S. AI ambitions.
Price Action: NVDA stock is down 3.32% at $98.12 at the last check on Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/downgrades/25/04/44875404/amkor-stock-under-pressure-analyst-cuts-rating-due-to-trade-policy-concerns-slowing-end-market-growth" target="_blank" rel="noreferrer noopener">Amkor Stock Under Pressure: Analyst Cuts Rating Due To Trade Policy Concerns, Slowing End Market Growth</a></li>
</ul>
Photo by glen photo via Shutterstock

Government

Regulations

Tech

Media

ASML

NVDA

SFTBF

SFTBY

Nvidia's Jensen Huang Meets Japanese PM To Discuss AI's Growing Energy Needs

Piper Sandler analyst Kashy Harrison maintains Fluence Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNC#NASDAQ">FLNC</a>) with a Neutral and lowers the price target from $10 to $4.

FLNC

Piper Sandler Maintains Neutral on Fluence Energy, Lowers Price Target to $4

Lixiang Education Shares Halted On Circuit Breaker To The Downside, Stock Now Down -72.7%

Piper Sandler analyst Kashy Harrison maintains First Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) with a Overweight and lowers the price target from $230 to $205.

FSLR

Piper Sandler Maintains Overweight on First Solar, Lowers Price Target to $205

Fast-food chain Chipotle Mexican Grill Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>) announced Monday that it is preparing its <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/n44894998/chipotle-signs-development-agreement-with-alsea-to-open-restaurants-in-mexico-for-the-first-time" rel="noreferrer noopener">first foray into the Mexican market</a> through a newly signed partnership with Latin American restaurant operator Alsea.
The move is expected to result in the opening of Chipotle&#8217;s inaugural restaurant in Mexico by early 2026, signaling a major step in the fast-casual chain&#8217;s international expansion.
Alsea, which operates major dining brands across Latin America and Europe, will collaborate with Chipotle on launching the brand.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/04/44876406/retail-slowdown-and-tariff-turbulence-hit-leisure-stocks-says-analyst" rel="noreferrer noopener">Retail Slowdown, Tariffs Jolt Leisure Stocks: Analyst Revises Estimates For Topgolf, Harley-Davidson And More</a>
Following this initial opening, the two companies plan to assess further growth potential in additional Latin American markets.
&#8220;We are confident that our responsibly sourced, classically-cooked real food will resonate with guests in&nbsp;Mexico,&#8221; said&nbsp;Chief Business Development Officer at Chipotle, Nate Lawton.
&#8220;The country&#8217;s familiarity with our ingredients and affinity for fresh food make it an attractive growth market for our company.&#8221;
Chipotle&#8217;s first international development agreement was made in 2023, with Alshaya Group, which has since brought five Chipotle locations to the Middle East, three in Kuwait and two in the UAE.
Globally, Chipotle already operates more than 3,700 outlets, including dozens of sites in Canada, the UK, France, and Germany.
The company aims to launch between 315 and 345 new restaurants in 2025 alone. Its long-term vision includes establishing up to 7,000 locations across the U.S. and Canada.
Chipotle reported a <a target="_blank" href="https://www.benzinga.com/general/restaurants/25/02/43479897/chipotle-q4-earnings-revenue-miss-eps-beat-focus-on-generous-portions-drives-food-costs-higher-shares-slide" rel="noreferrer noopener">13.1% increase in its fourth-quarter </a>revenue to $2.845 billion. The company expects full-year 2025 comparable restaurant sales growth in the low- to mid-single-digit range.&nbsp;
Price Action: CMG shares traded lower by 1.43% at $47.48 at the last check on Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44867319/chip-maker-micron-splits-into-four-business-units-to-accelerate-ai-strategy" target="_blank" rel="noreferrer noopener">Chip Maker Micron Splits Into Four Business Units To Accelerate AI Strategy</a></li>
</ul>
Photo by Northfoto via Shutterstock

Chipotle To Open First Mexico Restaurant By 2026

Piper Sandler analyst Andrew Liesch maintains Great Southern Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSBC#NASDAQ">GSBC</a>) with a Neutral and lowers the price target from $62 to $58.

GSBC

Piper Sandler Maintains Neutral on Great Southern Bancorp, Lowers Price Target to $58

<a href="https://www.supremecourt.gov/orders/ordersofthecourt" title="https://www.supremecourt.gov/orders/ordersofthecourt">https://www.supremecourt.gov/orders/ordersofthecourt</a>

Politics

SWBI

Supreme Court Declines To Hear Minnesota's Appeal Defending State's Age Minimum Of 21 To Carry Handguns In Public

Piper Sandler analyst Mark Fitzgibbon maintains Independent Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDB#NASDAQ">INDB</a>) with a Neutral and lowers the price target from $74 to $63.

INDB

Piper Sandler Maintains Neutral on Independent Bank, Lowers Price Target to $63

BWS Financial analyst Hamed Khorsand maintains Movado Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOV#NYSE">MOV</a>) with a Buy and maintains $31.5 price target.

BWS Financial Maintains Buy on Movado Group, Maintains $31.5 Price Target

WIIM

CING

Cingulate shares are trading lower after Ascendiant Capital cut its price target on the stock from $75 to $60.

Press Releases

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of TFI International

Legal

DEADLINE ALERT for ELF, FLNC, EU, and TFII: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

TFII LAWSUIT ALERT: The Gross Law Firm Notifies TFI International Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

ROSEN, A LEADING LAW FIRM, Encourages TFI International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TFII

TFI International Inc. Class Action: Levi & Korsinsky Reminds TFI International Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2025 - TFII

Shareholders that lost money on TFI International Inc. (TFII) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More

TFII Investors Have Opportunity to Lead TFI International Inc. Securities Fraud Lawsuit

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of TFI International

Shareholders of TFI International Inc. Should Contact The Gross Law Firm Before May 13, 2025 to Discuss Your Rights - TFII

TFI INTERNATIONAL INC. (NYSE: TFII) DEADLINE ALERT: Bernstein Liebhard LLP Reminds TFI International Inc. Investors of Upcoming Deadline

Comments

TFI International

ニュース

最新ニュース TFI International (NYSE:TFII) 株価情報

ニュース

パートナーシップ

ベンジンガ・グローバル